INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of InvestorsBusiness Wire • 03/14/24
The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of InvestorsBusiness Wire • 03/13/24
CDMO LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMOBusiness Wire • 03/07/24
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024GlobeNewsWire • 03/06/24
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023GlobeNewsWire • 12/07/23
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023GlobeNewsWire • 11/30/23
Down -22.27% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a TurnaroundZacks Investment Research • 11/28/23
Avid Bioservices (CDMO) Moves 9.0% Higher: Will This Strength Last?Zacks Investment Research • 11/15/23
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) ProgramsGlobeNewsWire • 11/08/23
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing FacilityGlobeNewsWire • 10/17/23
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO ConferenceGlobeNewsWire • 09/26/23
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023GlobeNewsWire • 09/07/23
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023GlobeNewsWire • 08/31/23